Share price should be $5.50 https://s27.q4cdn.com/906368049/files/News/2020/Zacks_SCR_Research_08242020_T.PMN_Vandermosten.pdf
$5.50 as present value share price estimated by independent analyst from Sacks Small Cap Research
The valuation method looked at market opportunity and probability of success in capturing that market opportunity to determine a present day market cap and pps.
Given bitten FDA approval, I think the probability of success for PMN is improving.
When will the market catch on?
Thanks for sharing that link to the report Mole101